Los Angeles Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$72.25 - $168.95 $4.95 Million - $11.6 Million	-68,539 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$125.56 - $178.74 $6.69 Million - $9.52 Million	-53,276 Reduced 43.74%	68,539 $11.7 Million
Q3 2020 Nov 02, 2020	SELL	$127.12 - $172.34 $960,010 - $1.3 Million	-7,552 Reduced 5.84%	121,815 $17.1 Million
Q2 2020 Aug 05, 2020	BUY	$93.0 - $171.7 $3.95 Million - $7.3 Million	42,523 Added 48.96%	129,367 $20.7 Million
Q1 2020 May 04, 2020	BUY	$82.38 - $131.64 $7.15 Million - $11.4 Million	86,844 New	86,844 $8.5 Million
Q2 2019 Jul 29, 2019	SELL	$112.21 - $151.95 $244,617 - $331,251	-2,180 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$106.67 - $151.68 $232,540 - $330,662	2,180 New	2,180 $260,000
Q2 2018 Jul 31, 2018	SELL	$71.74 - $153.69 $761,878 - $1.63 Million	-10,620 Closed	0 $0
Q1 2018 Apr 27, 2018	BUY	$54.02 - $82.27 $573,692 - $873,707	10,620 New	10,620 $787,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.